Home › Funds › TANG CAPITAL MANAGEMENT LLC › PMVP
TANG CAPITAL MANAGEMENT LLC position in PMVP
PMV PHARMACEUTICALS INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 7,285,085 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 0.56% of its reported portfolio and ranking #31 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed PMVP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's PMVP position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in PMVP in Q3 2025 at 4,785,201 shares (US$6.7M). The position peaked in Q3 2026 at 7,285,085 shares, worth US$12.2M. Across 5 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 7,285,085 shares valued at US$12.2M — an increase of 3,040,000 shares quarter over quarter.. Notable position changes include a 72% increase in Q3 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 4.79M | $6.70M | New |
| Q4 2025 | 4.94M | $6.17M | Add |
| Q1 2026 | 4.25M | $5.26M | Reduce |
| Q2 2026 | 4.25M | $5.69M | Hold |
| Q3 2026 | 7.29M | $12.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PMVP and 13F data
PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in PMVP — the largest reported positions include BML Capital Management, LLC (US$12.2M), Samsara BioCapital, LLC (US$12.1M), Sio Capital Management, LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PMVP
- BML Capital Management, LLC 7.33M sh · $12.24M · Q3 2026
- Samsara BioCapital, LLC 7.24M sh · $12.09M · Q3 2026
- Sio Capital Management, LLC 3.63M sh · $6.07M · Q3 2026
- Euclidean Capital LLC 2.63M sh · $4.39M · Q3 2026
- Boxer Capital Management, LLC 2.05M sh · $3.42M · Q3 2026
- Aldebaran Capital, LLC 489.54K sh · $817.53K · Q3 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held PMVP?
TANG CAPITAL MANAGEMENT LLC has disclosed PMVP holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is TANG CAPITAL MANAGEMENT LLC's current position in PMVP?
As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 7.29M shares of PMVP (PMV PHARMACEUTICALS INC), valued at $12.17M, representing 0.56% of its reported portfolio and ranking #31.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling PMVP?
In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC increased its position in PMVP. The position peaked in Q3 2026 at 7.29M shares.
Which other funds hold PMVP?
Other major institutional holders of PMVP include BML Capital Management, LLC, Samsara BioCapital, LLC, Sio Capital Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.